HAEM5:Volunteer Assignments and Opportunities

From Compendium of Cancer Genome Aberrations
Revision as of 13:55, 17 December 2023 by Jennelleh (talk | contribs)
Jump to navigation Jump to search
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (4th Edition) Content
Disease (5th Edition) Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Correlated Prior Disease Name (4th Edition) Notes
CHAPTER 2 (MYELOID PROLIFERATIONS AND NEOPLASMS)


Clonal haematopoiesis Disease Fabiola Quintero-Rivera (FQR)
Clonal cytopenias of undetermined significance Disease FQR
Chronic myeloid leukaemia Disease Jack Reid, MD (University of California, Irvine) Mark Evans, MD (University of California, Irvine) Fabiola Quintero-Rivera, MD (University of California, Irvine) FQR
Chronic neutrophilic leukaemia Disease Anamaria Munteanu, MD, Ph.D**, Harbor-UCLA Medical Center, Joseph J. Merlo Jr, MD. Ph.D**, Ashion Analytics, Fabiola Quintero-Rivera, University of California Irvine **contributed equally FQR
Chronic eosinophilic leukaemia Disease Chelsea D. Kramish; Daynna J.Wolff Pending Review* FQR
Polycythaemia vera Disease Gokce A. Toruner, MD, PhD UT MD Anderson Cancer Center FQR
Essential thrombocythaemia Disease Rebecca Smith, PhD, Director, Genetics Associates, Nashville, TN FQR
Primary myelofibrosis Disease T. Niroshi Senaratne, UCLA FQR
Juvenile myelomonocytic leukaemia Disease Assistant Professor, Pathology Associate Director | Division of Molecular Pathology, Genetics and Genomics Duke University Health System Clinical Laboratories FQR
Myeloproliferative neoplasm, NOS Disease Thomas Lee, MD, PhD, University of California, Los Angeles FQR
Cutaneous mastocytosis Disease S. Shawn Liu, MD, PhD and Thuy Phung, MD, PhD FQR
Systemic mastocytosis Disease Abdullah Osme, MD, University Hospitals Cleveland Medical Center, Case Western Reserve University Shashi Shetty, Ph.D. FACMG, FCCMG, University Hospitals Cleveland Medical Center, Case Western Reserve University FQR
Mast cell sarcoma Disease Jordan Lowery, MD and Thuy Phung, MD, PhD Department of Pathology, University of South Alabama, Mobile, AL FQR
Myelodysplastic neoplasm with low blasts and 5q deletion Disease FQR
Myelodysplastic neoplasm with low blasts and SF3B1 mutation Disease FQR
Myelodysplastic neoplasm with biallelic TP53 inactivation Disease FQR
Myelodysplastic neoplasm with low blasts Disease FQR
Myelodysplastic neoplasm, hypoplastic Disease FQR
Myelodysplastic neoplasm with increased blasts Disease Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA. FQR
Childhood myelodysplastic neoplasm with low blasts Disease Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA. FQR
Childhood myelodysplastic neoplasm with increased blasts Disease Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA. FQR
Chronic myelomonocytic leukaemia Disease Linsheng Zhang, MD, PhD FQR
Myelodysplastic/myeloproliferative neoplasm with neutrophilia Disease Linsheng Zhang, MD, PhD FQR
Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis Disease Anamaria Munteanu, MD, Ph.D, Harbor-UCLA Medical Center, Fabiola Quintero-Rivera, University of California Irvine FQR
Myelodysplastic/myeloproliferative neoplasm, NOS Disease Ruth MacKinnon PhD Victorian Cancer Cytogenetics Service Melbourne, Australia FQR
Myeloid/lymphoid neoplasm with PDGFRA rearrangement Disease Jay Alden, DO FQR
Myeloid/lymphoid neoplasm with PDGFRB rearrangement Disease Christopher Sullivan, MD, MPH and Daynna J. Wolff, PhD FQR
Myeloid/lymphoid neoplasm with FGFR1 rearrangement Disease Yanna Ding, MD PhD FQR
Myeloid/lymphoid neoplasm with JAK2 rearrangement Disease Jessica Snider, M.D. and Daynna J. Wolff, PhD FQR
Myeloid/lymphoid neoplasm with FLT3 rearrangement Disease FQR
Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion Disease FQR
Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes Disease FQR
Acute promyelocytic leukaemia with PML::RARA fusion Disease Yiming Zhong, Ph.D., Megan Piazza, Ph.D., and Shashi Shetty, Ph.D. Jennelle Hodge (JH)/ Malini Sathanoori (MS)
Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion Disease Christine Bryke, MD
Beth Israel Deaconess Medical Center, Boston, MA 		JH_MS
Acute myeloid leukaemia with CBFB::MYH11 fusion Disease Christine Bryke, MD
Beth Israel Deaconess Medical Center, Boston, MA 		JH_MS
Acute myeloid leukaemia with DEK::NUP214 fusion Disease JH_MS
Acute myeloid leukaemia with RBM15::MRTFA fusion Disease Jennelle C. Hodge, PhD, FACMG JH_MS
Acute myeloid leukaemia with BCR::ABL1 fusion Disease Kay Weng Choy MBBS, Monash Medical Centre JH_MS
Acute myeloid leukaemia with KMT2A rearrangement Disease Megan Piazza, Ph.D., Yiming Zhong, Ph.D., Shashi Shetty, Ph.D. JH_MS
Acute myeloid leukaemia with MECOM rearrangement Disease JH_MS
Acute myeloid leukaemia with NUP98 rearrangement Disease JH_MS
Acute myeloid leukaemia with NPM1 mutation Disease Xinjie Xu, PhD, FACMG JH_MS
Acute myeloid leukaemia with CEBPA mutation Disease Paul Defazio, MSc, Monash Health JH_MS
Acute myeloid leukaemia, myelodysplasia-related Disease Fei Yang, MD, FACMG
Oregon Health & Science University, Portland, OR 		JH_MS
Acute myeloid leukaemia with other defined genetic alterations Disease JH_MS
Acute myeloid leukaemia with minimal differentiation Disease Celeste Eno, PhD, Cedars Sinai Medical Center, Los Angeles, Fabiola Quintero-Rivera, MD, FACMG, University of California Irvine JH_MS
Acute myeloid leukaemia without maturation Disease Jennelle C. Hodge, PhD, FACMG JH_MS
Acute myeloid leukaemia with maturation Disease Jennelle C. Hodge, PhD, FACMG JH_MS
Acute basophilic leukaemia Disease Ashwini Yenamandra PhD FACMG JH_MS
Acute myelomonocytic leukaemia Disease Fei Yang, MD, FACMG
Oregon Health & Science University, Portland, OR 		JH_MS
Acute monocytic leukaemia Disease Fei Yang, MD, FACMG
Oregon Health & Science University, Portland, OR 		JH_MS
Acute erythroid leukaemia Disease Ashwini Yenamandra PhD FACMG JH_MS
Acute megakaryoblastic leukaemia Disease Fei Yang, MD, FACMG
Oregon Health & Science University, Portland, OR 		JH_MS
Myeloid sarcoma Disease Yalda Naeini, MD, School of Medicine at University of California Los Angeles Fabiola Quintero-Rivera, MD, FACMG, School of Medicine at University of California Irvine JH_MS
Myeloid neoplasm post cytotoxic therapy Disease Shawn A. Silver, DO, Shashi Shetty, Ph.D. JH_MS
Myeloid neoplasms associated with germline predisposition Disease JH_MS
Myeloid proliferations associated with Down syndrome Disease Linda D Cooley, MD, MBA, Children's Mercy Hospital, Kansas City, MO JH_MS
Mixed-phenotype acute leukaemia with BCR::ABL1 fusion Disease Tracy Tucker, PhD, FCCMG JH_MS
Mixed-phenotype acute leukaemia with KMT2A rearrangement Disease Tracy Tucker, PhD, FCCMG JH_MS
Acute leukaemia of ambiguous lineage with other defined genetic alterations Disease JH_MS
Mixed-phenotype acute leukaemia, B/myeloid Disease Priyatharsini Nirmalanantham, MD and Shashi Shetty, PhD JH_MS
Mixed-phenotype acute leukaemia, T/myeloid Disease Narsis Attar, MD, PhD, Fabiola Quintero-Rivera, MD University of California, Irvine JH_MS
Mixed-phenotype acute leukaemia, rare types Disease Elicia Goodale, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina JH_MS
Acute leukaemia of ambiguous lineage, NOS Disease JH_MS
Acute undifferentiated leukaemia Disease Amelia Nakanishi, MD and Shashi Shetty, PhD JH_MS
CHAPTER 3 (HISTIOCYTIC/DENRITIC CELL NEOPLASMS)


Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm Disease Greg Corboy (GC)
Blastic plasmacytoid dendritic cell neoplasm Disease Hao Liu, MD and Daynna J. Wolff, PhD GC
Langerhans cell histiocytosis Disease Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland GC
Langerhans cell sarcoma Disease Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland GC
Indeterminate dendritic cell tumour Disease GC
Interdigitating dendritic cell sarcoma Disease GC
Juvenile xanthogranuloma Disease GC
Erdheim-Chester disease Disease GC
Rosai-Dorfman Disease Disease GC
ALK-positive histiocytosis Disease GC
Histiocytic sarcoma Disease Marie-France Gagnon, MD, Mayo Clinic, Xinjie Xu, PhD FACMG, Mayo Clinic GC
CHAPTER 4 (B-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS)


Reactive B-cell rich lymphoid proliferations that can mimic lymphoma Disease GC
IgG4-related disease Disease GC
Unicentric Castleman disease Disease GC
Idiopathic multicentric Castleman disease Disease GC
KSHV/HHV8-associated multicentric Castleman disease Disease Sudha Arumugam, MD GC
B-lymphoblastic leukaemia/lymphoma Disease Holli Drendel (HD)
B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy Disease Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG HD
B-lymphoblastic leukaemia/lymphoma with hypodiploidy Disease Ashwini Yenamandra PhD FACMG Lisa Smith PhD FACMG Yassmine Akkari PhD FACMG HD
B-lymphoblastic leukaemia/lymphoma with iAMP21 Disease Holli M. Drendel, PhD, FACMGG, Carolinas Pathology Group, Charlotte HD
B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion Disease Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG HD
B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features Disease Mark G. Evans, MD, University of California, Irvine Fabiola Quintero-Rivera, MD, University of California, Irvine HD
B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement Disease Yassmine Akkari Nicolas Millan HD
B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion Disease Marilena Melas, PhD; Yassmine Akkari, PhD, FACMG Cancer Category/Type B-Lymphoblastic Leukemia/Lymphoma HD
B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features Disease HD
B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion Disease Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO HD
B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion Disease Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO HD
B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion Disease HD
B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations Disease HD
B-lymphoblastic leukaemia/lymphoma, NOS Disease HD
Monoclonal B-cell lymphocytosis Disease Shivani Golem (SG)
Chronic lymphocytic leukaemia/small lymphocytic lymphoma Disease Jamie Nagy, PhD, University of Iowa Honey Reddi, PhD SG
Hairy cell leukaemia Disease *Snehal Patel, MD, PhD SG
Splenic marginal zone lymphoma Disease *Snehal Patel, MD, PhD SG
Splenic diffuse red pulp small B-cell lymphoma Disease *Snehal Patel, MD, PhD SG
Splenic B-cell lymphoma/leukaemia with prominent nucleoli Disease *Snehal Patel, MD, PhD SG
Lymphoplasmacytic lymphoma Disease Kapitolina Semenova, MD, Jack Reid, MD, Fabiola Quintero-Rivera, MD Departments of Pathology, Laboratory Medicine, and *Pediatrics, Division of Genetic and Genomic Medicine, University of California, Irvine (UCI) SG
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue Disease SG
Primary cutaneous marginal zone lymphoma Disease SG
Nodal marginal zone lymphoma Disease Andrew Ly, DO and Shivani Golem, PhD, FACMG SG
Paediatric nodal marginal zone lymphoma Disease * Kathleen M. Schieffer, PhD * Ruthann Pfau, PhD SG
In situ follicular B-cell neoplasm Disease Rachel D. Burnside, PhD, MBA, FACMGG SG
Follicular lymphoma Disease Ruthann Pfau, PhD, FACMG, Nationwide Children's Hospital Rachel D. Burnside, PhD, MBA, FACMG, University of Florida SG
Paediatric-type follicular lymphoma Disease *Kathleen M. Schieffer, PhD *Ruthann Pfau, PhD, FACMG SG
Duodenal-type follicular lymphoma Disease SG
Primary cutaneous follicle centre lymphoma Disease Linlin Gao, MD, PhD and Shivani Golem, PhD, FACMG SG
In situ mantle cell neoplasm Disease Rina Kansal, MD; Versiti Blood Center of Wisconsin SG
Mantle cell lymphoma Disease * Mahsa Khanlari, MD * Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas SG
Leukaemic non-nodal mantle cell lymphoma Disease
SG
Transformations of indolent B-cell lymphomas Disease SG
Diffuse large B-cell lymphoma, NOS Disease Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center GC
T-cell/histiocyte-rich large B-cell lymphoma Disease GC
Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC and BCL2 rearrangements Disease Kate Berry, MBBS, BBus (Hons), Pathology Queensland GC
ALK-positive large B-cell lymphoma Disease Manando Nakasaki, MD, PhD (University of California, Irvine) Fabiola Quintero-Rivera, MD, FACMG (University of California, Irvine) GC
Large B-cell lymphoma with IRF4 rearrangement Disease *Afia Hasnain, MBBS, PhD GC
High grade B-cell lymphoma with 11q aberrations Disease Lauren Shealy, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina GC
Lymphomatoid granulomatosis Disease GC
EBV-positive diffuse large B-cell lymphoma Disease GC
Diffuse large B-cell lymphoma associated with chronic inflammation Disease GC
Fibrin-associated large B-cell lymphoma Disease GC
Fluid overload-associated large B-cell lymphoma Disease GC
Plasmablastic lymphoma Disease Mark Evans, MD (University of California, Irvine) Fabiola Quintero-Rivera, MD (University of California, Irvine) GC
Primary large B-cell lymphoma of immune-privileged sites Disease Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center GC
Primary cutaneous diffuse large B-cell lymphoma, leg type Disease GC
Intravascular large B-cell lymphoma Disease Kate Berry, MBBS, BBus (Hons), Pathology Queensland GC
Primary mediastinal large B-cell lymphoma Disease GC
Mediastinal grey zone lymphoma Disease GC
High-grade B-cell lymphoma, NOS Disease Aiko Otsubo, PhD, Indiana University GC
Burkitt lymphoma Disease Becky Leung, MBBS (Hons), BSc, Pathology Queensland GC
Primary effusion lymphoma Disease GC
KSHV/HHV8-positive diffuse large B-cell lymphoma Disease GC
KSHV/HHV8-positive germinotropic lymphoproliferative disorder Disease GC
Hyperplasias arising in immune deficiency/dysregulation Disease GC
Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation Disease Anna Shestakova, MD, PhD, Fellow, University of Utah/ARUP Laboratories Fabiola Quintero-Rivera, MD, Professor, University of California Irvine (UCI) GC
EBV-positive mucocutaneous ulcer Disease GC
Lymphomas arising in immune deficiency / dysregulation Disease GC
Inborn error of immunity-associated lymphoid proliferations and lymphomas Disease GC
Classic Hodgkin lymphoma Disease Patricia V. Hernandez, M.D., Washington University School of Medicine GC
Nodular lymphocyte predominant Hodgkin lymphoma Disease GC
CHAPTER 5 (T-CELL AND NK-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS)

||

|| || || || ||
CHAPTER 6 (STROMA-DERIVED NEOPLASMS OF LYMPHOID TISSUES)

||

|| || || || ||
CHAPTER 7 (GENETIC TUMOUR SYNDROMES)

||

|| || || || ||
Cold agglutinin disease Disease SP
IgM monoclonal gammopathy of undetermined significance Disease SP
Non-IgM monoclonal gammopathy of undetermined significance Disease SP
Monoclonal gammopathy of renal significance Disease SP
Immunoglobulin-related (AL) amyloidosis Disease Heather E. Williams, PhD, MS, PgD, ErCLG SP
Monoclonal immunoglobulin deposition disease Disease Chen Yang, MD, PhD, University of Michigan SP
Mu heavy chain disease Disease SP
Gamma heavy chain disease Disease Manisha Brahmbhatt-Sutariya Asst. Professor, Dept. of Pathology and Human Anatomy Technical Supervisor, Clinical Genetics Laboratory Loma Linda University, Medical Center, CA SP
Alpha heavy chain disease Disease SP
Plasmacytoma Disease SP
Plasma cell myeloma / multiple myeloma Disease *Huan Mo, MD, MS *Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas SP
Plasma cell neoplasms with associated paraneoplastic syndrome Disease Sohini Anand, MBBS Tharanga Niroshini Senaratne, PhD SP
Kikuchi-Fujimoto disease Disease SP
Autoimmune lymphoproliferative syndrome Disease SP
Indolent T-lymphoblastic proliferation Disease SP
T-prolymphocytic leukaemia Disease SP
T-large granular lymphocytic leukaemia Disease *Michelle Don, MD, MS SP
NK-large granular lymphocytic leukaemia Disease Michelle Don, MD SP
Adult T-cell leukaemia/lymphoma Disease Prasad R. Kopparapu, PhD and Ferrin C. Wheeler, PhD, FACMG Vanderbilt University Medical Center SP
Sezary syndrome Disease Madison E. Hannay, DO, Medical University of South Carolina Tingting Barrett, MD, Medical University of South Carolina Daynna J. Wolff, PhD, Medical University of South Carolina SP
Aggressive NK-cell leukaemia Disease Shanelle De Lancy, MD, Shashirekha Shetty, PhD SP
Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder Disease SP
Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder Disease SP
Mycosis fungoides Disease Jane Scribner, MD and Daynna J. Wolff, PhD SP
Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis Disease SP
Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma Disease Theresa Spivey, MD, Shashirekha Shetty, PhD SP
Subcutaneous panniculitis-like T-cell lymphoma Disease SP
Primary cutaneous gamma/delta T-cell lymphoma Disease SP
Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma Disease SP
Primary cutaneous peripheral T-cell lymphoma, NOS Disease SP
Indolent T-cell lymphoma of the gastrointestinal tract Disease Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD SP
Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract Disease SP
Enteropathy-associated T-cell lymphoma Disease *Derick Okwan-Duodu, MD, PhD *Sumire Kitahara, MD SP
Monomorphic epitheliotropic intestinal T-cell lymphoma Disease Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD SP
Intestinal T-cell lymphoma, NOS Disease Derick Okwan MD, PhD (Stanford Medicine, CA) Sumire Kitahara MD (Cedars-Sinai, CA) SP
Hepatosplenic T-cell lymphoma Disease *Michelle Don, MD, MS SP
ALK-positive anaplastic large cell lymphoma Disease SP
ALK-negative anaplastic large cell lymphoma Disease Miguel Gonzalez Mancera, MD Sumire Kitahara, MD Cedars-Sinai, Los Angeles, CA SP
Breast implant-associated anaplastic large cell lymphoma Disease Derick Okwan-Duodu, MD, PhD; Sumire Kitahara, MD Cedars-Sinai Medical Center SP
Nodal TFH cell lymphoma, angioimmunoblastic-type Disease * Sara Akhavanfard, M.D., Ph.D. * Ruthann Pfau, Ph.D., FACMG SP
Nodal TFH cell lymphoma, follicular-type Disease SP
Nodal TFH cell lymphoma, NOS Disease Hans Magne Hamnvåg, MD Kamran Mirza, MD, PhD SP
Peripheral T-cell lymphoma, NOS Disease SP
EBV-positive nodal T- and NK-cell lymphoma Disease SP
Extranodal NK/T-cell lymphoma Disease SP
Severe mosquito bite allergy Disease SP
Hydroa vacciniforme lymphoproliferative disorder Disease SP
Systemic chronic active EBV disease Disease SP
Systemic EBV-positive T-cell lymphoma of childhood Disease *Lisa A. Lansdon, PhD & Linda D. Cooley, MD, MBA SP
Follicular dendritic cell sarcoma Disease Anna Heimes Dillon, MD and Shivani Golem, PhD, FACMG SP
EBV-positive inflammatory follicular dendritic cell sarcoma Disease SP
Fibroblastic reticular cell tumour Disease SP
Intranodal palisaded myofibroblastoma Disease SP
Littoral cell angioma Disease SP
Splenic hamartoma Disease SP
Sclerosing angiomatoid nodular transformation (SANT) of spleen Disease SP
B-lymphoblastic leukaemia/lymphoma Disease YA
B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy Disease Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG YA
B-lymphoblastic leukaemia/lymphoma with hypodiploidy Disease Ashwini Yenamandra PhD FACMG Lisa Smith PhD FACMG Yassmine Akkari PhD FACMG YA
B-lymphoblastic leukaemia/lymphoma with iAMP21 Disease Holli M. Drendel, PhD, FACMGG, Carolinas Pathology Group, Charlotte YA
B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion Disease Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG YA
B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features Disease Mark G. Evans, MD, University of California, Irvine Fabiola Quintero-Rivera, MD, University of California, Irvine YA
B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement Disease Yassmine Akkari Nicolas Millan YA
B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion Disease Marilena Melas, PhD; Yassmine Akkari, PhD, FACMG Cancer Category/Type B-Lymphoblastic Leukemia/Lymphoma YA
B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features Disease YA
B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion Disease Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO YA
B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion Disease Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO YA
B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion Disease YA
B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations Disease YA
B-lymphoblastic leukaemia/lymphoma, NOS Disease YA
T-lymphoblastic leukaemia / lymphoma, NOS Disease YA
Early T-precursor lymphoblastic leukaemia / lymphoma Disease Fei Yang, MD, FACMG, Kaiser Permanente Northwest YA
Fanconi anaemia Disease NA
Bloom syndrome Disease NA
Ataxia-telangiectasia syndrome Disease NA
RASopathies Disease NA
Retrieved from "https://ccga.io/index.php?title=HAEM5:Volunteer_Assignments_and_Opportunities&oldid=13888"